Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr;69(4):545-550.
doi: 10.1161/HYPERTENSIONAHA.116.08956.

Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble

Teresa M Seccia  1 , Brasilina Caroccia  1 , Gail K Adler  1 , Giuseppe Maiolino  1 , Maurizio Cesari  1 , Gian Paolo Rossi  2
Affiliations
Review

Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble

Teresa M Seccia et al. Hypertension. 2017 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest/Disclosure: None

Figures

Figure 1
Figure 1. Mechanisms by which aldosterone excess favors onset of atrial fibrillation
Aldosterone affects all cell types that are the primary constituents of cardiac tissue: a) cardiomyocytes, which constitute 30% of myocardial cells, but 75% of myocardial tissue, b) fibroblasts (30-50% of myocardial cells), c) endothelial cells (20-30% of myocardial cells), and also activates macrophages. Aldosterone excess induces enlargement of cardiomyocytes and remodeling leading to left ventricular hypertrophy (LVH) that predisposes to diastolic dysfunction. Aldosterone excess also activates the transition of fibroblasts into myofibroblasts, which produce collagen and other extracellular matrix proteins, favoring fibrosis. Fibrotic tissue induces electrical heterogeneity of the myocardium that causes re-entry circuits, thereby leading to onset of atrial fibrillation. Endothelial cells exposed to aldosterone excess undergo transition into myofibroblasts (endothelial-to-mesenchymal transition, EMT), which contribute to the development of fibrosis. The activation of the mineralocorticoid receptor (MR) on the monocytes/macrophages favors inflammation, necrosis and reparative fibrosis, and eventually atrial fibrillation. Aldosterone excess induces hypokalemia, which causes prolongation of PQ interval and changes in the duration of A and E waves, leading to abnormal LV filling that promotes AF, which in turn favors heart failure.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–2962. - PubMed
    1. Stewart S, Hart CL, Hole DJ, McMurray JJ. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart. 2001;86:516–521. - PMC - PubMed
    1. Naccarelli GV, Varker H, Lin J, Schulman KL. Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol. 2009;104:1534–1539. - PubMed
    1. Naccarelli GV, Johnston SS, Dalal M, Lin J, Patel PP. Rates and implications for hospitalization of patients >/=65 years of age with atrial fibrillation/flutter. Am J Cardiol. 2012;109:543–549. - PubMed
    1. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol. 1998;82:2N–9N. - PubMed

Publication types

MeSH terms